These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10629773)

  • 1. Pathophysiology of the oxidative stress and its implication in uremia and dialysis.
    Galli F; Canestrari F; Bellomo G
    Contrib Nephrol; 1999; 127():1-31. PubMed ID: 10629773
    [No Abstract]   [Full Text] [Related]  

  • 2. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
    Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity.
    Miyata T; Saito A; Kurokawa K; van Ypersele de Strihou C
    Nephrol Dial Transplant; 2001; 16 Suppl 4():8-11. PubMed ID: 11402090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of oxidative and carbonyl stress to long-term uremic complications.
    Miyata T; Kurokawa K; van Ypersele de Strihou C
    Kidney Int Suppl; 2000 Aug; 76():S120-5. PubMed ID: 10936808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modulation of AGEs: a unique role for redox-active metal ions.
    Weiss MF; Saxena AK; Monnier VM
    Perit Dial Int; 1999; 19 Suppl 2():S62-7. PubMed ID: 10406496
    [No Abstract]   [Full Text] [Related]  

  • 6. Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism.
    Miyata T; Kurokawa K; VAN Ypersele DE Strihou C
    J Am Soc Nephrol; 2000 Sep; 11(9):1744-1752. PubMed ID: 10966500
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenic role of advanced glycation end-products (AGEs): an overview.
    Weiss MF
    Perit Dial Int; 1999; 19 Suppl 2():S47-52. PubMed ID: 10406493
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxidative stress and inflammation: Implications in uremia and hemodialysis.
    Libetta C; Sepe V; Esposito P; Galli F; Dal Canton A
    Clin Biochem; 2011 Oct; 44(14-15):1189-98. PubMed ID: 21777574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients.
    Kalousová M; Zima T; Tesar V; Sulková S; Fialová L
    Kidney Int Suppl; 2003 May; (84):S62-4. PubMed ID: 12694311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonyl stress: increased carbonyl modification of proteins by autoxidation products of carbohydrates and lipids in uremia.
    Miyata T; Kurokawa K
    Int J Artif Organs; 1999; 22(4):195-8. PubMed ID: 10466948
    [No Abstract]   [Full Text] [Related]  

  • 11. Profound mishandling of protein glycation degradation products in uremia and dialysis.
    Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
    J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid metabolism in dialysis patients-the story gets more complicated.
    Ponda MP; Barash I
    Semin Dial; 2008; 21(5):390-4. PubMed ID: 18764791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia.
    Witko-Sarsat V; Nguyen-Khoa T; Jungers P; Drüeke TB; Descamps-Latscha B
    Nephrol Dial Transplant; 1999; 14 Suppl 1():76-8. PubMed ID: 10048460
    [No Abstract]   [Full Text] [Related]  

  • 14. [Disorders of lipid metabolism in uremia].
    Cerezo Morales S; Escobar Jiménez F; Núñez Carril J; Asensio Peinado C; García-Valdescasa Valverde J; Raya Muñóz J; Peña Yáñez A
    Rev Clin Esp; 1978 Jan; 148(2):175-9. PubMed ID: 635270
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of hemodialysis on the oxidative stress and antioxidants.
    Dursun E; Ozben T; Süleymanlar G; Dursun B; Yakupoglu G
    Clin Chem Lab Med; 2002 Oct; 40(10):1009-13. PubMed ID: 12476939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonyl stress: increased carbonyl modification of tissue and cellular proteins in uremia.
    Miyata T; Izuhara Y; Sakai H; Kurokawa K
    Perit Dial Int; 1999; 19 Suppl 2():S58-61. PubMed ID: 10406495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive carbonyl compounds as uremic toxins.
    Miyata T; Akhand AA; Kurokawa K; Nakashima I
    Contrib Nephrol; 2001; (133):71-80. PubMed ID: 11477755
    [No Abstract]   [Full Text] [Related]  

  • 18. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").
    Miyata T; Sugiyama S; Saito A; Kurokawa K
    Kidney Int Suppl; 2001 Feb; 78():S25-31. PubMed ID: 11168978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of the glycoxidation and lipoxidation reactions in the pathogenesis of dialysis-related amyloidosis (Review).
    Sugiyama S; Miyata T; Inagi R; Kurokawa K
    Int J Mol Med; 1998 Nov; 2(5):561-5. PubMed ID: 9858652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are advanced oxidation protein products potential uremic toxins?
    Witko-Sarsat V; Gausson V; Descamps-Latscha B
    Kidney Int Suppl; 2003 May; (84):S11-4. PubMed ID: 12694298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.